APEX-Agents · GPT-5.4 · dual
World125_Task01_NA
GPT-5.4 on APEX-Agents: World125_Task01_NA (dual harness). Browse score, rubric, and public trace.
Grader rubric
Criteria verdict
States that Impact Therapeutic is a company that primarily sells branded drugs
States the average of COGS as a share of revenue for companies that primarily sell branded drugs is 23%
States that the global COGS as a share of revenue for Impact Therapeutics in 2024 is higher than the average of 23%
States that the US COGS as a share of revenue for Impact Therapeutics in 2024 is higher than the average of 23%
Prompt excerpt
Task context
Using the 2024 annual report, identify whether Impact Therapeutics sells primarily branded drugs. A company sells primarily branded drugs if the majority of drugs have launch dates within the last 7 years. Please use the BCG report to determine the average COGS as a % of revenue for competitors in Impact Therapeutics' segment, based on whether they sell primarily generic drugs, branded, or a mix. Round to the nearest %. In both the global and US geos, state whether Impact Therapeutics is above the segment average calculated from the data in the BCG report. Write your response as a reply to me here.
Response trace
Agent response, tools, files, and edits
On mobile, open the full trace for the best view of the agent response, tool calls, file reads, edits, and grading context.
Open mobile trace